Content
Search
Navigation
Sitemap
About us
Pipeline & science
Overview
Obesity
Type 2 Diabetes Mellitus (T2DM)
Acute Ischemic Stroke (AIS)
Hypertension
Our expertise
Overview
Our strategic partners
Global opportunities
Join us
Press releases
Contact
简体中文
Search
简体中文
Navigation
Press releases
14 Apr 2025
CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions
Read article
26 Feb 2025
CORXEL Bolsters Leadership Team with Seasoned CFO Kevin Xie to Drive Next Phase of Company Growth
Read article
20 Feb 2025
CORXEL Announces China National Medical Products Administration Approval of the Clinical Trial Application for ORION, the Global Registrational Study of JX10 in Patients with Acute Ischemic Stroke
Read article
22 Jan 2025
CORXEL Announces Upcoming Presentation at the International Stroke Conference 2025 on JX10 Improving Neurological Outcomes in Acute Lacunar Infarct
Read article
17 Jan 2025
CORXEL Announces NMPA Acceptance of New Drug Application for Etripamil
Read article
23 Dec 2024
CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes
Read article
Load more
